BLOOD TRANSFUSION IN THE MANAGEMENT OF THOSE INJURED: RATIONAL WAYS TO REDUCE ITS VOLUME IN THE ACUTE PERIOD OF WOUND DISEASE (report three)

Goal: to develop the intensive care programme aimed at the rational reduction of blood transfusions in those with massive hemorrhage of the very severe degree. Materials. Specific course of traumatic disease was analyzed in 112 patients with multiple traumas and acute massive hemorrhage of the very severe degree. Retrospective group 1 included 52 patients, prospective groups 2 and 3 – 39 and 21 patients respectively. Management tactics did not differ principally but for the therapy purposefully aimed at the rational reduction of transfusion of erythrocyte preparations. Results. Using differential management tactics for coagulopathy during acute period of wound disease in those with massive hemorrhage of the very severe degree aimed at the rational reduction of blood transfusions is accompanied by the tendency of lower severity of wound disease in general. Conclusion: In order to reduce the volume of blood transfusions during traumatic shock in those injured it is feasible to use preparations containing key coagulation factors. Rational reduction of blood transfusion volume is accompanied by the tendency of the better treatment results in such patients in general.

1. Ostapchenko D.A. Gipoksiya i ee korrektsiya u bolnykh s tyazheloy tupoy i sochetannoy travmoy grudi. Avtoref. diss. dokt. med. nauk. [Hypoxia and its management in those suffering from severe concurrent blunt chest trauma. Doct. Diss.]. 03.00.37. Moscow, 2005, 45 p.

2. Samokhvalov I.M., Badalov V.I., Nemchenko N.S. et al. Safety criteria of blood reinfusion in field military surgery and trauma surgery. Voenno-Med. Journal, 2014, vol. CCCXXXV, no. 3, pp. 26-30. (In Russ.)

3. Samokhvalov I.M., Bogomolov B.N., Smirnov S.А. et al. Blood transfusions in the management of those injured: individual indications in post-shock periods of wound disease (report two). Messenger of Anesthesiology and Resuscitation, 2016, vol. 13, no. 6, pp. 48-53. (In Russ.)

4. Samokhvalov I.M., Nedomolkin S.V., Smirnov S.А. et al. Blood transfusions in the management of those injured: impact on the course of wound disease (report one). Messenger of Anesthesiology and Resuscitation, 2016, vol. 13, no. 4, pp. 42-47. (In Russ.)

5. Usenko O.V., Shifrin G.А. Intensivnaya terapiya pri krovopotere. [Intensive care of hemorrhage]. Kiev, Zdorovye Publ., 1995, 235 p.

6. Shanin V.Yu., Gavrilin S.V., Budko А.А. Using of perftoranum in the intensive care of respiratory disorders of those with severe concurrent trauma. Tez. dokladov nauchn. konf. po aktualnym voprosam kliniki, diagnostiki i lecheniyu. [Abstract book of Conference on Actual Clinical, Diagnostic and Treatment Issues]. St. Petersburg, Voenn.-Med. Akad. Publ., 1995 pp. 201-202. (In Russ.)

7. Efendiev M.M. Perftoran v kompleksnom lechenii postgemorragicheskoy anemii i profilaktike tromboembolicheskikh oslozhneniy pri ginekologicheskoy patologii. Avtoref. diss. kand. med. nauk. [Perftoranum in the integral treatment of post-hemorrhage anemia and prevention of thromboembolic complications in gynecological disorders. Cand. Diss.]. Moscow, 2009. 24 p.

8. Brohi K.Н. Acute traumatic coagulopahy. J. Trauma, 2003, vol. 54, no. 3, pp. 1127‒1130.

9. Cambell H., Stokes E., Bargo D. Quanting the healthcare costs of treating severely bleeding major trauma patients: a national study of England. Crit. Care, 2015, vol. 19, no. 1, pp. 276-279.

10. Combat anesthesia: the first 24 hours. Senior edit. Buckenmaier Ch., Mahoney P. Sam Houston, The Surgeon General Borden Institute, 2015. 240 p.

11. Dutton R., Parr M., Tortella B. Recombinant activated factor VII in trauma patients: results from the CONTROL Trial. J. Trauma, 2011, vol. 71, no. 1, pp. 12-19.

12. Hauser C., Boffard K., Datton R. Control study group. Results of the control trial: efficacy and safety of recombinated activated Factor VII management of refractory traumatic hemorrhage. J. Trauma, 2010, vol. 69, no. 3, pp. 489‒500.

13. Johansson P. Current management of massive hemorrhage in trauma patients. Resuscitation and Emergency Medicine, 2012, no. 2. pp. 2‒10.

14. Khan S., Davenport R., Raza I. Damage control resuscitation using blood component therapy in standart doses has a limited effect on coagulopathy during truma hemorrhage. Intens. Care Med., 2015, vol. 41. no. 2. pp. 239-247.

15. Rossaint R., Boullion B., Cemy V. The Europeon guideline on management of major bleeding and coagulopathy following trauma. Crit. Care, 2016, vol. 20, no. 2, pp. 2-55.